Ongoing Etonogestrel Contraceptive Implant Use Throughout Pregnancy.

[1]  J. Sheeder,et al.  Risk of luteal phase pregnancy with any-cycle-day initiation of subdermal contraceptive implants. , 2017, Contraception.

[2]  M. Lehtinen,et al.  Hormone concentrations throughout uncomplicated pregnancies: a longitudinal study , 2016, BMC Pregnancy and Childbirth.

[3]  L. Finer,et al.  Changes in Use of Long-Acting Reversible Contraceptive Methods Among U.S. Women, 2009–2012 , 2015, Obstetrics and gynecology.

[4]  Gynecologists.  Practice bulletin no. 130: prediction and prevention of preterm birth. , 2012, Obstetrics and gynecology.

[5]  L. Chan,et al.  Pharmacokinetics of the etonogestrel contraceptive implant in obese women. , 2012, American journal of obstetrics and gynecology.

[6]  J. Sheeder,et al.  Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference? , 2012, American journal of obstetrics and gynecology.

[7]  O. Graesslin,et al.  The contraceptive efficacy of Implanon®: A review of clinical trials and marketing experience , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

[8]  C. Campagnoli,et al.  Classification and pharmacology of progestins. , 2003, Maturitas.